Target intelligence / Profile preview

Subchondral bone

Molecular classification
Other
01

Overview

Subchondral bone is the specialized layer of bone located immediately beneath the articular cartilage within a joint, comprising the subchondral bone plate and the underlying trabecular bone (Source: PubMed, PMID: 23435154). It functions as a vital structural component that absorbs mechanical loads and provides nutritional support to the overlying avascular cartilage through a network of microscopic channels and vessels (Source: StatPearls, Osteoarthritis). In the context of joint diseases such as osteoarthritis, the subchondral bone undergoes pathological remodeling characterized by increased bone turnover, sclerosis, and the formation of bone marrow lesions (Source: NIH, Bone Marrow Lesions). Although it is an anatomical structure rather than a single molecular target, it is a primary focus for therapeutic intervention aimed at slowing joint degeneration. Pharmacological strategies often involve modulating bone metabolism through the inhibition of osteoclasts or the regulation of signaling pathways like TGF-beta and Wnt to maintain joint integrity (Source: Journal of Orthopaedic Translation, 2020). Drugs such as bisphosphonates and cathepsin K inhibitors are frequently studied for their ability to stabilize this tissue and prevent the progression of osteoarthritis (Source: PubMed, PMID: 31581015). The health of the subchondral bone is intrinsically linked to the health of the articular cartilage, forming what is known as the osteochondral unit.

Other names
Subchondral bone plateSubchondral trabecular boneSubchondral bone unitOsteochondral unit
02

Mechanism of action

Inhibition of osteoclast-mediated bone resorption and modulation of bone turnover to reduce sclerosis and structural degradation.

03

Biological functions

Structural supportShock absorptionBone remodelingNutrient transportJoint homeostasis
04

Disease associations

OsteoarthritisOsteonecrosisBone marrow lesionsStress fractureOsteoporosis
05

Safety considerations

Atypical femoral fracturesOsteonecrosis of the jawSystemic bone density alterationsPotential for impaired fracture healing
06

Interacting drugs

Alendronate

4 more in the full profile.

07

Biomarkers

C-terminal telopeptide of type I collagen (CTX-I)N-terminal telopeptide of type I collagen (NTX-I)OsteocalcinBone-specific alkaline phosphatase (BSAP)Bone marrow lesions (BMLs) on MRI

Beyond the preview

Go deeper on Subchondral bone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Subchondral bone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call